ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marcello Leopoldo Enza Lacivita |
| Publication date | December 30, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |